Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 4
2005 2
2006 2
2007 2
2008 5
2009 4
2010 8
2011 4
2012 9
2013 6
2014 8
2015 1
2016 2
2017 3
2018 1
2019 3
2020 4
2021 2
2022 2
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Aptamers as Therapeutics.
Nimjee SM, White RR, Becker RC, Sullenger BA. Nimjee SM, et al. Among authors: white rr. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:61-79. doi: 10.1146/annurev-pharmtox-010716-104558. Annu Rev Pharmacol Toxicol. 2017. PMID: 28061688 Free PMC article. Review.
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.
Ozmadenci D, Shankara Narayanan JS, Andrew J, Ojalill M, Barrie AM, Jiang S, Iyer S, Chen XL, Rose M, Estrada V, Molinolo A, Bertotto T, Mikulski Z, McHale MC, White RR, Connolly DC, Pachter JA, Kuchroo VK, Stupack DG, Schlaepfer DD. Ozmadenci D, et al. Among authors: white rr. Proc Natl Acad Sci U S A. 2022 Apr 26;119(17):e2117065119. doi: 10.1073/pnas.2117065119. Epub 2022 Apr 25. Proc Natl Acad Sci U S A. 2022. PMID: 35467979 Free PMC article.
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan JS, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P, Pu M, Mikulski Z, Miller A, Messer K, Carson D, Schoenberger S, White RR. Shankara Narayanan JS, et al. Among authors: white rr. J Immunother Cancer. 2023 Jan;11(1):e006133. doi: 10.1136/jitc-2022-006133. J Immunother Cancer. 2023. PMID: 36634919 Free PMC article. Clinical Trial.
Incidental Gallbladder Cancer: Permission to Operate.
Erdem S, White RR. Erdem S, et al. Among authors: white rr. Ann Surg Oncol. 2020 Apr;27(4):980-982. doi: 10.1245/s10434-019-08080-6. Epub 2019 Nov 13. Ann Surg Oncol. 2020. PMID: 31722073 No abstract available.
Clinical Management: Resectable Disease.
White RR, Lowy AM. White RR, et al. Cancer J. 2017 Nov/Dec;23(6):343-349. doi: 10.1097/PPO.0000000000000291. Cancer J. 2017. PMID: 29189330 Review.
Aptamer applications for targeted cancer therapy.
Barbas AS, Mi J, Clary BM, White RR. Barbas AS, et al. Among authors: white rr. Future Oncol. 2010 Jul;6(7):1117-26. doi: 10.2217/fon.10.67. Future Oncol. 2010. PMID: 20624124 Review.
Aptamers for Targeted Drug Delivery.
Ray P, White RR. Ray P, et al. Among authors: white rr. Pharmaceuticals (Basel). 2010 May 27;3(6):1761-1778. doi: 10.3390/ph3061761. Pharmaceuticals (Basel). 2010. PMID: 27713328 Free PMC article. Review.
71 results